RAPID BIOSENSE LLC NPI 1164049524

NPI Details

RAPID BIOSENSE LLC is a clinical medical laboratory in Plymouth, MI. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. RAPID BIOSENSE LLC NPI is 1164049524. The provider is registered as an organization entity type.

The provider's business location address is:

46701 COMMERCE CENTER DR
PLYMOUTH, MI
ZIP 48170-475
Phone: (734) 255-3254

The provider's authorized official is John William Cunningham .
The authorized official title is Ceo and has the following contact phone number (734) 747-5225.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled (HCPCS:P9603)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b (HCPCS:87636)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Hemoglobin a1c level (HCPCS:83036)
• Magnesium level (HCPCS:83735)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Blood test, clotting time (HCPCS:85610)
• Bacterial colony count, urine (HCPCS:87086)
• Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge (HCPCS:P9604)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Levetiracetam level (HCPCS:80177)
• Iron level (HCPCS:83540)
• Valproic acid level, total (HCPCS:80164)
• Ferritin (blood protein) level (HCPCS:82728)
• Folic acid level, rbc (HCPCS:82747)
• Prealbumin (protein) level (HCPCS:84134)
• Uric acid level, blood (HCPCS:84550)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Thyroid hormone, t3 measurement, free (HCPCS:84481)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Ammonia level (HCPCS:82140)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Phosphate level (HCPCS:84100)

The enumeration date for this NPI number is 7/1/2020 and was last updated on 7/1/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: